Correlation Between Stoke Therapeutics and Solid Biosciences
Can any of the company-specific risk be diversified away by investing in both Stoke Therapeutics and Solid Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Stoke Therapeutics and Solid Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Stoke Therapeutics and Solid Biosciences LLC, you can compare the effects of market volatilities on Stoke Therapeutics and Solid Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Stoke Therapeutics with a short position of Solid Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Stoke Therapeutics and Solid Biosciences.
Diversification Opportunities for Stoke Therapeutics and Solid Biosciences
0.67 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Stoke and Solid is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Stoke Therapeutics and Solid Biosciences LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Solid Biosciences LLC and Stoke Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Stoke Therapeutics are associated (or correlated) with Solid Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Solid Biosciences LLC has no effect on the direction of Stoke Therapeutics i.e., Stoke Therapeutics and Solid Biosciences go up and down completely randomly.
Pair Corralation between Stoke Therapeutics and Solid Biosciences
Given the investment horizon of 90 days Stoke Therapeutics is expected to generate 1.1 times less return on investment than Solid Biosciences. But when comparing it to its historical volatility, Stoke Therapeutics is 1.1 times less risky than Solid Biosciences. It trades about 0.03 of its potential returns per unit of risk. Solid Biosciences LLC is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 632.00 in Solid Biosciences LLC on August 31, 2024 and sell it today you would lose (62.00) from holding Solid Biosciences LLC or give up 9.81% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Stoke Therapeutics vs. Solid Biosciences LLC
Performance |
| Timeline |
| Stoke Therapeutics |
| Solid Biosciences LLC |
Stoke Therapeutics and Solid Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Stoke Therapeutics and Solid Biosciences
The main advantage of trading using opposite Stoke Therapeutics and Solid Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Stoke Therapeutics position performs unexpectedly, Solid Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Solid Biosciences will offset losses from the drop in Solid Biosciences' long position.| Stoke Therapeutics vs. Adaptimmune Therapeutics Plc | Stoke Therapeutics vs. Black Diamond Therapeutics | Stoke Therapeutics vs. Relay Therapeutics | Stoke Therapeutics vs. Pliant Therapeutics |
| Solid Biosciences vs. Century Therapeutics | Solid Biosciences vs. Edgewise Therapeutics | Solid Biosciences vs. C4 Therapeutics | Solid Biosciences vs. Mineralys Therapeutics, Common |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Stocks Directory Find actively traded stocks across global markets | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |